500 patients67,039 observations150 daysLIVE

Patient P-03200

Synthetic patientONX-7 · Day 145 · 75+ · F · baseline S16Open companion preview
Therapy response
Stable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
36%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S16

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Nutritional resilience-10
  • Toxicity+9
  • Inflammatory activity+8
  • Treatment adherence-8
  • GI instability+7

What helped?

No interventions yet.

    LIFE OS recommendation
    Dosing / Timing Recommendation DT-01
    59%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 85% showed improvement
    • median effect visible after 5 days

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production 45
      • MicrobiomeF. prausnitzii depleted
      • Daily logFibre intake low in recent food logs
    • Mucosal barrier integrity 30
      • MicrobiomeAkkermansia low → thinner mucus layer
    • Autonomic recovery 20
      • Wearable3,791 steps/day
    • Inflammatory signalling 15
      • WearableHRV 25 ms, trending down
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 4.5 · butyrate capacity 48/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    29 ms
    Sleep
    7.6 h
    Steps
    4,034
    Resting HR
    58 bpm
    Daily log: GI score 39, nutritional resilience 47, adherence 87.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0348049%S2061
    P-0328748%S1755
    P-0343848%S0951
    P-0345348%S1656
    P-0330147%S0262
    P-0347447%S1256
    P-0310946%S2063
    P-0317146%S1055
    P-0342846%S1662
    P-0315445%S1653
    P-0321945%S1749
    P-0305244%S0344